$15M for Tetraphase

Tetraphase Pharmaceuticals of Watertown, MA, announced today that it has raised a $15 million second tranche of its $25 million Series A financing. The cash comes from Mediphase Venture Partners, CMEA Ventures, Fidelity Biosciences, Flagship Ventures, and Skyline Ventures, who backed the startup when it spun out of Harvard in 2006 to develop synthetic antibiotics, as we explained in a profile of Tetraphase last fall.

Rebecca is Xconomy's co-founder. Follow @

Trending on Xconomy